Human bone marrow‐derived MSCs were obtained from the Texas A&M Health Science Centre College of Medicine, Institute for Regenerative Medicine (Temple, Texas, US), a NIH repository. The cells met all the criteria for the classification as MSCs as defined by the International Society of Cellular Therapy 29. For inhibitor experiments using Cytochalasin B (Sigma‐Aldrich, Dorset, UK, www.sigmaaldrich.com), cells were incubated in complete α‐MEM supplemented with 1% Fetal Calf Serum (FCS) and 500 nM of inhibitor for 1.5–2 hours 5% CO2 and 37°C. Cells were then washed three times with Dulbecco's phosphate buffered saline (DPBS) prior to in vitro and in vivo studies.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.